Literature DB >> 17254003

Massive SCA7 expansion detected in a 7-month-old male with hypotonia, cardiomegaly, and renal compromise.

Andrea Whitney1, Ming Lim, Dipak Kanabar, Jean-Pierre Lin.   

Abstract

Infantile spinocerebellar ataxia type 7 (SCA7) is phenotypically different from the child-onset and adult-onset cases, presenting as a multisystem disorder associated with pathologically large CAG trinucleotide repeat sequences. We describe a case study of a male who presented at 5 months of age with marked motor delay, failure to thrive, and a patent ductus arteriosus. He later developed renal failure of uncertain aetiology. The infant became progressively hypotonic, and cardiac and renal function deteriorated further; he died at the age of 11 months of multisystem failure. Family history revealed a diagnosis of SCA7 in the infant's father, paternal grandfather, and aunt. DNA analysis confirmed an expanded trinucleotide repeat in the SCA7 locus of about 240 repeats, suggesting a diagnosis of infantile SCA7. Striking anticipation is seen in SCA7, particularly with paternal transmission. The underlying pathophysiological processes seem to involve alteration in transcriptional regulation and a selective neuronal vulnerability to the widely distributed abnormal protein product. This case report reviews the current literature relating to infantile SCA7 and raises awareness of this rare but important phenotype.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17254003     DOI: 10.1111/j.1469-8749.2007.00140.x

Source DB:  PubMed          Journal:  Dev Med Child Neurol        ISSN: 0012-1622            Impact factor:   5.449


  7 in total

1.  Consensus and controversies in best practices for molecular genetic testing of spinocerebellar ataxias.

Authors:  Jorge Sequeiros; Sara Seneca; Joanne Martindale
Journal:  Eur J Hum Genet       Date:  2010-02-24       Impact factor: 4.246

2.  Vision Loss in a Teenage Girl With Postconcussion Syndrome.

Authors:  Hasenin Al-Khersan; Tim Hain; Michael A Grassi
Journal:  JAMA Ophthalmol       Date:  2017-01-01       Impact factor: 7.389

Review 3.  Molecular Targets and Therapeutic Strategies in Spinocerebellar Ataxia Type 7.

Authors:  Anna Niewiadomska-Cimicka; Yvon Trottier
Journal:  Neurotherapeutics       Date:  2019-10       Impact factor: 7.620

4.  Nonallele specific silencing of ataxin-7 improves disease phenotypes in a mouse model of SCA7.

Authors:  Pavitra S Ramachandran; Ryan L Boudreau; Kellie A Schaefer; Albert R La Spada; Beverly L Davidson
Journal:  Mol Ther       Date:  2014-06-16       Impact factor: 11.454

5.  Metabolic and Organelle Morphology Defects in Mice and Human Patients Define Spinocerebellar Ataxia Type 7 as a Mitochondrial Disease.

Authors:  Jacqueline M Ward; Colleen A Stoyas; Pawel M Switonski; Farid Ichou; Weiwei Fan; Brett Collins; Christopher E Wall; Isaac Adanyeguh; Chenchen Niu; Bryce L Sopher; Chizuru Kinoshita; Richard S Morrison; Alexandra Durr; Alysson R Muotri; Ronald M Evans; Fanny Mochel; Albert R La Spada
Journal:  Cell Rep       Date:  2019-01-29       Impact factor: 9.423

6.  Requirement for zebrafish ataxin-7 in differentiation of photoreceptors and cerebellar neurons.

Authors:  Constantin Yanicostas; Elisa Barbieri; Masahiko Hibi; Alexis Brice; Giovanni Stevanin; Nadia Soussi-Yanicostas
Journal:  PLoS One       Date:  2012-11-30       Impact factor: 3.240

Review 7.  Human Induced Pluripotent Stem Cell-Based Modelling of Spinocerebellar Ataxias.

Authors:  Bart P C van de Warrenburg; Hans van Bokhoven; Marina P Hommersom; Ronald A M Buijsen; Willeke M C van Roon-Mom
Journal:  Stem Cell Rev Rep       Date:  2021-05-25       Impact factor: 5.739

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.